Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Ku, M.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(3)
+
-
Availability
Open access
(3)
+
-
Metadata Only
(1)
+
-
Creation Date
2022
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(4)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(4)
+
-
Topic
XPO1
(2)
+
-
Author
Bakhshi, S.
(4)
+
-
Casasnovas, R.O.
(4)
+
-
Cavallo, F.
(4)
+
-
Choquet, S.
(4)
+
-
Follows, G.
(4)
+
-
Gurion, R.
(4)
+
-
Hamad, N.
(4)
+
-
Kalakonda, N.
(4)
+
-
Ku, M.
(4)
+
-
Kuruvilla, J.
(4)
+
-
Maerevoet, M.
(4)
+
-
Neste, E. van den
(4)
+
-
Shacham, S.
(4)
+
-
Thieblemont, C.
(4)
+
-
Warzocha, K.
(4)
+
-
Caimi, P.
(3)
+
-
Cruz, F. de la
(3)
+
-
Egyed, M.
(3)
+
-
Goy, A.
(3)
+
-
Jaeger, U.
(3)
+
-
Kauffman, M.G.
(3)
+
-
Ma, X.W.
(3)
+
-
Offner, F.
(3)
+
-
Samal, P.
(3)
+
-
Sancho, J.M.
(3)
+
-
Schuster, M.
(3)
+
-
Shah, J.
(3)
+
-
Vermaat, J.S.P.
(3)
+
-
Bouabdallah, R.
(2)
+
-
Canales, M.
(2)
+
-
Chamoun, K.
(2)
+
-
Hill, B.
(2)
+
-
Hill, B.T.
(2)
+
-
Nagy, A.
(2)
+
-
Zijlstra, J.
(2)
+
-
Zijlstra, J.M.
(2)
+
-
Show more
Language
en
(4)
+
-
Search results
(1 - 4 of 4)
show grid
show list
save search
Effect of prior therapy and disease refractoriness on the efficacy and safety of oral selinexor in patients with diffuse large B-cell lymphoma (DLBCL)
Comparison of the effectiveness and safety of the oral selective inhibitor of nuclear export, selinexor, in diffuse large B cell lymphoma subtypes
Health-related quality of life and utility outcomes with selinexor in relapsed/refractory diffuse large B-cell lymphoma
Single Agent Oral Selinexor Demonstrates Deep and Durable Responses in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) in Both GCB and Non GCB Subtypes: The Phase 2b Sadal Study